http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002521470-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate | 1999-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002521470-A |
| titleOfInvention | Distamycin sulfide derivative, method for producing the same, and use thereof as an antitumor agent |
| abstract | (57) Abstract: n is 2, 3 or 4; A is a bond, a C 1 -C 4 alkylene or a C 2 -C 4 alkenylene group; R 1 and R 2 may be the same or different , Hydrogen, C 1 -C 4 alkyl optionally substituted by one or more fluorine atoms, and C 1 -C 4 alkoxy; X is a halogen atom; , (C), (d), (e), (f), (g), (h), (i), (j) and (k); R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 may be the same or different and are selected from hydrogen or C 1 -C 4 alkyl; R 11 is hydrogen, C 1 -C 4 alkyl or hydroxyl; wherein m is 0, 1 or 2, a compound which is a sulfurized distamycin derivative of the formula (I) Or a pharmaceutically acceptable salt of the compound is useful as an antitumor agent. Embedded image |
| priorityDate | 1998-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.